Exposure of immunologically naive laboratory rodents to antigen via the airways. Where does tolerance stop and sensitization begin

Clinical and Experimental Allergy

Volumn 42, Issue 11, 2012, Pages 1552-1565

  Guibas, G V ^a,b   Makris, M ^a   Spandou, E ^b   Priftis, K N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Aeroallergen; Asthma; Experimental protocol; Laboratory rodents; Sensitization

Indexed keywords

AEROALLERGEN; ALLERGEN; LIPOPOLYSACCHARIDE; OVALBUMIN; UNCLASSIFIED DRUG;

AIRWAY; CLINICAL PROTOCOL; ENVIRONMENTAL FACTOR; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT ALLERGY; REVIEW; SENSITIZATION; STRESS; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; ANIMALS, LABORATORY; ANTIGENS; DISEASE MODELS, ANIMAL; ENVIRONMENT; FEMALE; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; MALE; MICE; RATS; RESPIRATORY HYPERSENSITIVITY;

EID: 84868123653     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03974.x     Document Type: Review

References (136)

1. Zosky GR, Sly PD. Animal models of asthma. Clin Exp Allergy 2007; 37:973-88.
2. Farraj AK, Harkema JR, Jan TR, Kaminski NE. Immune responses in the lung and local lymph node of A/J mice to intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicol Pathol 2003; 31:432-47.
3. Cates EC, Fattouh R, Wattie J et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol 2004; 173:6384-92.
4. Okano M, Nishizaki K, Abe M et al. Strain-dependent induction of allergic rhinitis without adjuvant in mice. Allergy 1999; 54:593-601.
5. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992; 89:1127-38.
6. Holt PG, Britten D, Sedgwick JD. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology 1987; 60:97-102.
7. Sedgwick JD, Holt PG. Suppression of IgE responses in inbred rats by repeated respiratory tract exposure to antigen: responder phenotype influences isotype specificity of induced tolerance. Eur J Immunol 1984; 14:893-7.
8. Wolvers DA, Coenen-de Roo CJ, Mebius RE et al. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999; 162:1994-8.
9. Wolvers DA, van der Cammen MJ, Kraal G. Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses. Immunology 1997; 92:328-33.
10. Tournoy KG, Hove C, Grooten J, Moerloose K, Brusselle GG, Joos GF. Animal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma? Clin Exp Allergy 2006; 36:8-20.
11. Van Hove CL, Maes T, Joos GF, Tournoy KG. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol 2007; 36:573-84.
12. Holt PG, Batty JE, Turner KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981; 42:409-17.
13. Holt PG. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol Today 1994; 15:484-9.
14. + T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J Exp Med 1998; 187:721-31.
15. Cates EC, Fattouh R, Johnson JR, Llop-Guevara A, Jordana M. Modeling responses to respiratory house dust mite exposure. Contrib Microbiol 2007; 14:42-67.
16. Hamelmann E, Oshiba A, Loader J et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997; 155:819-25.
17. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 2000; 105:765-75.
18. McCusker C, Chicoine M, Hamid Q, Mazer B. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease. J Allergy Clin Immunol 2002; 110:891-8.
19. Shinagawa K, Kojima M. Mouse model of airway remodeling. Strain differences. Am J Respir Crit Care Med 2003; 168:959-67.
20. Fattouh R, Pouladi MA, Alvarez D et al. House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation. Am J Respir Crit Care Med 2005; 172:314-21.
21. Li N, Wang M, Bramble LA et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect 2009; 117:1116-23.
22. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849-56.
23. + T cells. J Immunol 1999; 163:2592-600.
24. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2:725-31.
25. Swirski FK, Gajewska BU, Alvarez D et al. Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in mice. Clin Exp Allergy 2002; 32:411-21.
26. Johnson JR, Wiley RE, Fattouh R et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004; 169:378-85.
27. Barbey C, Donatelli-Dufour N, Batard P, Corradin G, Spertini F. Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance. Clin Exp Allergy 2004; 34:654-62.
28. Janssen EM, Wauben MH, Jonker EH et al. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1999; 21:21-9.
29. Chapman MD, Pomés A, Breiteneder H, Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol 2007; 119:414-20.
30. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002; 169:5904-11.
31. Gough L, Sewell HF, Shakib F. The proteolytic activity of the major dust mite allergen Der p 1 enhances the IgE antibody response to a bystander antigen. Clin Exp Allergy 2001; 31:1594-8.
32. Shakib F, Schulz O, Sewell H. A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol Today 1998; 19:313-6.
33. Comoy EE, Pestel J, Duez C et al. The house dust mite allergen, Dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between IL-4 and IFN-gamma. J Immunol 1998; 160:2456-62.
34. Köhl J, Baelder R, Lewkowich IP et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 2006; 116:783-96.
35. Lambrecht BN. An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization. J Clin Invest 2006; 116:628-32.
36. Alvarez D, Swirski FK, Yang TC et al. Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and nonmucosal tissues. J Immunol 2006; 176:2568-80.
37. Janssen EM, van Oosterhout AJ, van Rensen AJ, van Eden W, Nijkamp FP, Wauben MH. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J Immunol 2000; 164:580-8.
38. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitize mice. J Exp Med 1993; 178:1783-8.
39. O'Brien R, Ooi MA, Clarke AH, Thomas WR. Immunologic responses following respiratory sensitization to house dust mite allergens in mice. Immunol Cell Biol 1996; 74:174-9.
40. Birrell MA, Van Oosterhout AJ, Belvisi MG. Do the current house dust mite-driven models really mimic allergic asthma? Eur Respir J 2010; 36:1220-1.
41. Ostroukhova M, Seguin-Devaux C, Oriss TB et al. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest 2004; 114:28-38.
42. Pauluhn J, Poole A. Brown Norway rat asthma model of diphenylmethane-4, 4'-diisocyanate (MDI): determination of the elicitation threshold concentration of after inhalation sensitization. Toxicology 2011; 281:15-24.
43. Barone KS, Tolarova DD, Ormsby I, Doetschman T, Michael JG. Induction of oral tolerance in TGF-beta 1 null mice. J Immunol 1998; 161:154-60.
44. Cohn L. Food for thought: can immunological tolerance be induced to treat asthma? Am J Respir Cell Mol Biol 2001; 24:509-12.
45. Lundin BS, Karlsson MR, Svensson LA, Hanson LA, Dahlgren UI, Telemo E. Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes. Clin Exp Immunol 1999; 116:181-7.
46. Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest 2000; 106:935-7.
47. Wiedermann U, Jahn-Schmid B, Bohle B et al. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J Allergy Clin Immunol 1999; 103:1202-10.
48. Nakao A, Kasai M, Kumano K, Nakajima H, Kurasawa K, Iwamoto I. High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways. Int Immunol 1998; 10:387-94.
49. Ebino K, Lemus R, Karol MH. The importance of the diluent for airway transport of toluene diisocyanate following intranasal dosing of mice. Inhal Toxicol 1999; 11:171-85.
50. Southam DS, Dolovich M, O'Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 2002; 282:833-9.
51. Elena G, Puig NR, Bay ML et al. Inhalatory anesthetic (halothane) associated changes in the immune response in mice. Int J Immunopharmacol 1997; 19:699-707.
52. Lockwood LL, Silbert LH, Laudenslager ML, Watkins LR, Maier SF. Anesthesia-induced modulation of in vivo antibody levels: a study of pentobarbital, chloral hydrate, methoxyflurane, halothane, and ketamine/xylazine. Anesth Analg 1993; 77:769-74.
53. Puig NR, Elena GA, Barragán J, Comba JO, Amerio N. Oxygen tension-associated changes on secondary immune response in halothane or isoflurane anesthetized mice. Acta Anaesthesiol Scand 1995; 39:945-8.
54. Mercier FJ, Naline E, Bardou M et al. Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane. Eur Respir J 2002; 20:286-92.
55. Habre W, Peták F, Sly PD, Hantos Z, Morel DR. Protective effects of volatile agents against methacholine-induced bronchoconstriction in rats. Anesthesiology 2001; 94:348-53.
56. Borges MC, Marchica CL, Narayanan V, Ludwig MS. Effect of allergen challenge under isoflurane and halothane anesthesia in hyperresponsiveness and inflammation in a murine model of allergic asthma. Am J Respir Crit Care Med 2011; 183:A2882.
57. Park KW, Dai HB, Lowenstein E, Kocher ON, Sellke FW. Isoflurane- and halothane-mediated dilation of distal bronchi in the rat depends on the epithelium. Anesthesiology 1997; 86:1078-87.
58. Puig NR, Elena GA, Barragán J, Comba JO, Amerio N. Halothane-associated enhancement of the secondary immune response to sheep erythrocytes in mice: cell transfer studies. Acta Anaesthesiol Scand 1993; 37:647-51.
59. Colucci D, Harvey G, Gayol MC, Elena G, Puig N. Halothane anesthesia in mice: effect on the phagocytic activity and respiratory burst of peritoneal macrophages. Neuroimmunomodulation 2011; 18:11-8.
60. Hamra JG, Yaksh TL. Halothane inhibits T cell proliferation and interleukin-2 receptor expression in rats. Immunopharmacol Immunotoxicol 1996; 18:323-36.
61. Puig NR, Amerio N, Piaggio E, Barragán J, Comba JO, Elena GA. Effects of halothane reexposure in female mice and their offspring. Reprod Toxicol 1999; 13:361-7.
62. Hofstetter C, Flondor M, Boost KA et al. A brief exposure to isoflurane (50 s) significantly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharmacol 2005; 5:1519-22.
63. Holt PG, McMenamin C. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin Exp Allergy 1989; 19:255-62.
64. Faria AM, Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 1999; 73:153-264.
65. Russo M, Nahori MA, Lefort J et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001; 24:518-26.
66. Knippels LM, Penninks AH, van Meeteren M, Houben GF. Humoral and cellular immune responses in different rat strains on oral exposure to ovalbumin. Food Chem Toxicol 1999; 37:881-8.
67. Matheson JM, Johnson VJ, Vallyathan V, Luster MI. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol Sci 2005; 84:88-98.
68. Fox PC, Siraganian RP. IgE antibody suppression following aerosol exposure to antigens. Immunology 1981; 43:227-34.
69. Rumold R, Jyrala M, Diaz-Sanchez D. Secondhand smoke induces allergic sensitization in mice. J Immunol 2001; 167:4765-70.
70. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993; 178:889-99.
71. Singh P, Daniels M, Winsett DW et al. Phenotypic comparison of allergic airway responses to house dust mite in three rat strains. Am J Physiol Lung Cell Mol Physiol 2003; 284:588-98.
72. Jansen HM. The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Allergy 1996; 51:279-92.
73. Holt PG, Clough JB, Holt BJ et al. Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992; 22:1093-9.
74. Holt PG, Vines J, Britten D. Suppression of IgE responses by antigen inhalation: failure of tolerance mechanism(s) in newborn rats. Immunology 1988; 63:591-3.
75. Al-Garawi A, Fattouh R, Botelho F et al. Influenza A facilitates sensitization to house dust mite in infant mice leading to an asthma phenotype in adulthood. Mucosal Immunol 2011; 4:682-94.
76. Phipps S, Hansbro N, Lam CE, Foo SY, Matthaei KI, Foster PS. Allergic sensitization is enhanced in early life through toll-like receptor 7 activation. Clin Exp Allergy 2009; 39:1920-8.
77. Lundin BS, Dahlgren UI, Hanson LA, Telemo E. Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats. Scand J Immunol 1996; 43:56-63.
78. Yamatomo T, Okano M, Ono T et al. Sex-related differences in the initiation of allergic rhinitis in mice. Allergy 2001; 56:525-31.
79. Rinner I, Schauenstein K, Mangge H, Porta S, Kvetnansky R. Opposite effects of mild and severe stress on in vitro activation of rat peripheral blood lymphocytes. Brain Behav Immun 1992; 6:130-40.
80. Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005; 5:23-9.
81. Portela Cde P, Massoco Cde O, de Lima WT, Palermo-Neto J. Stress-induced increment on total bronchoalveolar cell count in OVA-sensitized rats. Physiol Behav 2001; 72:415-20.
82. Joachim RA, Cifuentes LB, Sagach V et al. Stress induces substance P in vagal sensory neurons innervating the mouse airways. Clin Exp Allergy 2006; 36:1001-10.
83. Pavlovic S, Liezmann C, Blois SM et al. Substance P is a key mediator of stress-induced protection from allergic sensitization via modified antigen presentation. J Immunol 2011; 186:848-55.
84. Joachim RA, Quarcoo D, Arck PC, Herz U, Renz H, Klapp BF. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med 2003; 65:811-5.
85. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009; 16:300-17.
86. Pavlovic S, Liezmann C, Daniltchenko M et al. Stress protects from allergic sensitisation via Substance-P modified antigen presentation. Exp Dermatol 2008; 17:631.
87. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotrophin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999; 13:225-39.
88. Joachim RA, Sagach V, Quarcoo D, Dinh QT, Arck PC, Klapp BF. Effect of stress on eotaxin and expression of adhesion molecules in a murine model of allergic airway inflammation. J Neuroimmunol 2007; 182:55-62.
89. Yang PC, Jury J, Söderholm JD, Sherman PM, McKay DM, Perdue MH. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006; 168:104-14.
90. Dhabhar FS, Viswanathan K. Short-term stress experienced at time of immunization induces a long-lasting increase in immunologic memory. Am J Physiol Regul Integr Comp Physiol 2005; 289:738-44.
91. Iwakabe K, Shimada M, Ohta A et al. The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant immunity in mice. Immunol Lett 1998; 62:39-43.
92. Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 1997; 11:286-306.
93. Chida Y, Sudo N, Sonoda J, Hiramoto T, Kubo C. Early-life psychological stress exacerbates adult mouse asthma via the hypothalamus-pituitary-adrenal axis. Am J Respir Crit Care Med 2007; 175:316-22.
94. Von Hertzen LC. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J Allergy Clin Immunol 2002; 109:923-8.
95. Riedel F, Krämer M, Scheibenbogen C, Rieger CH. Effects of SO2 exposure on allergic sensitization in the guinea pig. J Allergy Clin Immunol 1988; 82:527-34.
96. Osebold JW, Gershwin LJ, Zee YC. Studies on the enhancement of allergic lung sensitization by inhalation of ozone and sulfuric acid aerosol. J Environ Pathol Toxicol 1980; 3:221-34.
97. Riedel F, Hasenauer E, Barth PJ, Koziorowski A, Rieger CH. Formaldehyde exposure enhances inhalative allergic sensitization in the guinea pig. Allergy 1996; 51:94-9.
98. Tarkowski M, Gorski P. Increased IgE antiovalbumin level in mice exposed to formaldehyde. Int Arch Allergy Immunol 1995; 106:422-4.
99. Harkema JR, Hotchkiss JA, Barr EB et al. Long-lasting effects of chronic ozone exposure on rat nasal epithelium. Am J Respir Cell Mol Biol 1999; 20:517-29.
100. Stämpfli MR, Wiley RE, Neigh GS et al. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 1998; 102:1704-14.
101. Swirski FK, Sajic D, Robbins CS, Gajewska BU, Jordana M, Stämpfli MR. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol 2002; 169:3499-506.
102. Stämpfli MR, Scott Neigh G, Wiley RE et al. Regulation of allergic mucosal sensitization by interleukin-12 gene transfer to the airway. Am J Respir Cell Mol Biol 1999; 21:317-26.
103. Ritz SA, Gajewska BU, Stämpfli MR, Jordana M. Determinants of the immune-inflammatory response in allergic airway inflammation: overview of antigen presentation and cellular activation. J Allergy Clin Immunol 2000; 106:206-12.
104. + Tcr alpha-/beta- lymphocytes (putative gamma/delta T cells). Immunology 1991; 74:234-9.
105. Schwarze J, Gelfand EW. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur Respir J 2002; 19:341-9.
106. Holt PG, Vines J, Bilyk N. Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice. Int Arch Allergy Appl Immun 1988; 86:121-3.
107. Yamamoto N, Suzuki S, Shirai A et al. Dendritic cells are associated with augmentation of antigen sensitization by influenza A virus infection in mice. Eur J Immunol 2000; 30:316-26.
108. Brimnes MK, Bonifaz L, Steinman RM, Moran TM. Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J Exp Med 2003; 198:133-44.
109. Sakamoto M, Ida S, Takishima T. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J Immunol 1984; 132:2614-7.
110. Suzuki S, Suzuki Y, Yamamoto N, Matsumoto Y, Shirai A, Okubo T. Influenza A virus infection increases IgE production and airway responsiveness in aerosolized antigen-exposed mice. J Allergy Clin Immunol 1998; 102:732-40.
111. Al-Garawi AA, Fattouh R, Walker TD et al. Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease. J Immunol 2009; 182:3095-104.
112. Yamamoto N, Suzuki S, Suzuki Y et al. Immune response induced by airway sensitization after influenza A virus infection depends on timing of antigen exposure in mice. J Virol 2001; 75:499-505.
113. Leibovitz E, Freihorst J, Piedra PA, Ogra PL. Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus. Implication in virally induced allergy. Int Arch Allergy Appl Immunol 1988; 86:112-6.
114. Freihorst J, Piedra PA, Okamoto Y, Ogra PL. Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proc Soc Exp Biol Med 1988; 188:191-7.
115. O'Donnell DR, Openshaw PJ. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998; 28:1501-8.
116. Riedel F, Krause A, Slenczka W, Rieger CH. Parainfluenza-3-virus infection enhances allergic sensitization in the guinea pig. Clin Exp Allergy 1996; 26:603-9.
117. Lukacs NW, Tekkanat KK, Berlin A et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001; 167:1060-5.
118. Siegle JS, Hansbro N, Herbert C et al. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 2010; 3:11-4.
119. Simecka JW, Jackson RJ, Kiyono H, McGhee JR. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract. Infect Immun 2000; 68:672-9.
120. Lambrecht BN, Kleinjan A. Mouse models of asthma and rhinitis to study the role of dendritic cells in sensitization and development of inflammation. Drug Discov Today 2006; 3:205-11.
121. Pierre P, Denis O, Bazin H, Mbella EM, Vaerman JP. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur J Immunol 1992; 22:3179-82.
122. Kulhankova K, George CL, Kline JN et al. Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses. Clin Exp Allergy 2009; 39:1069-79.
123. Wagner JG, Van Dyken SJ, Wierenga JR, Hotchkiss JA, Harkema JR. Ozone exposure enhances endotoxin-induced mucous cell metaplasia in rat pulmonary airways. Toxicol Sci 2003; 74:437-46.
124. Sun J, Li F, Chen J, Xu J. Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats. Ann Clin Lab Sci 2004; 34:181-6.
125. Wagner JG, Hotchkiss JA, Harkema JR. Effects of ozone and endotoxin coexposure on rat airway epithelium: potentiation of toxicant-induced alterations. Environ Health Perspect 2001; 109:591-8.
126. Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN. Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol 2003; 171:4592-603.
127. Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993; 177:1773-7.
128. Wan GH, Li CS, Lin RH. Airborne endotoxin exposure and the development of airway antigen-specific allergic responses. Clin Exp Allergy 2000; 30:426-32.
129. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-51.
130. Schramm CM, Puddington L, Wu C et al. Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease. Am J Pathol 2004; 164:295-304.
131. Tulić MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 22:604-12.
132. Hollingsworth JW, Whitehead GS, Lin KL et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006; 176:5856-62.
133. Gerhold K, Blümchen K, Bock A et al. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110:110-6.
134. Kips JC, Anderson GP, Fredberg JJ et al. Murine models of asthma. Eur Respir J 2003; 22:374-82.
135. Watanabe J, Miyazaki Y, Zimmerman GA, Albertine KH, McIntyre TM. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper reactivity. J Biol Chem 2003; 278:42361-8.
136. Schramm CM, Guernsey L, Secor E, Thrall RS. Tolerance induced by chronic inhaled antigen in a murine asthma model is not mediated by endotoxin. Biochim Biophys Acta 2006; 1762:499-501.